Neutrophils in galactose-fed dogssuppressed apoptosis and increased adhesion to retinal capillary endothelial cells

Journal of Diabetes and its Complications

Volumn 13, Issue 3, 1999, Pages 151-158

  Ohta, Nobuo ^a   Tsai, Jen Yue ^a   Secchi, E Filippo ^a   Kador, Peter F ^a   Sato, Sanai ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; GALACTOSE; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL DAMAGE; CONTROL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; DOG; ENDOTHELIUM CELL; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; RETINA CAPILLARY;

ANIMALS; APOPTOSIS; CAPILLARIES; CELL ADHESION; CYCLOHEXIMIDE; DIABETES MELLITUS, EXPERIMENTAL; DNA FRAGMENTATION; DOGS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GALACTOSE; MALE; NEUTROPHILS; PROTEIN KINASE C; PROTEIN SYNTHESIS INHIBITORS; RETINAL VESSELS; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032872579     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(99)00040-9     Document Type: Article

References (42)

1. Atherton A., Born G.V. Quantitative investigations of the adhesiveness of circulating polymorphonuclear leukocytes to blood vessel walls. J Physiol. 222:1972;447-474.
2. Schmid-Schonbein G.W., Usami S., Skalak R., Chien S. The interaction of leukocytes in capillary and postcapillary vessels. Microvasc Res. 19:1980;45-70.
3. Fantone J.C., Ward P.A. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Physiol. 107:1982;397-418.
4. Bagge U., Amundson B., Lauritzen C. White blood cell deformability and plugging of skeletal muscle capillaries in hemorrhagic shock. Acta Physiol Scand. 108:1980;159-163.
5. Barroso-Aranda J., Schmid-Schonbein G.W., Zweifach B.W., Engler R.L. Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock. Circ Res. 63:1988;437-447.
6. Kaminski P.M., Proctor K.G. Attenuation of no-reflow phenomenon, neutrophil activation, and reperfusion injury in intestinal microcirculation by topical adenosine. Circ Res. 65:1989;426-435.
7. Pecsvarady Z., Fisher T.C., Darwin C.H., Fabok A., Maqueda T.S., Saad M.F., Meiselman H.J. Decreased polymorphonuclear leukocyte deformability in NIDDM. Diabetes Care. 17:1994;57-63.
8. Braun R.D., Fisher T.C., Meiselman H.J., Hatchell D.L. Decreased deformability of polymorphonuclear leukocytes in diabetic cats. Microcirculation. 3:1996;271-278.
9. Harris A.G., Skalak T.C., Hatchell D.L. Leukocyte-capillary plugging and network resistance are increased in skeletal muscle of rats with streptozotocin-induced hyperglycemia. Int J Microcirc Clin Exp. 14:1994;159-166.
10. Miyamoato K., Ogura Y., Kenmochi S., Honda Y. Role of leukocytes in diabetic microcirculatory disturbances. Microvasc Res. 54:1997;43-48.
11. Kim J.A., Berliner J.A., Natarajan R.D., Nadler J.L. Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes. 43:1994;1103-1107.
12. Wierusz-Wysocka B., Wykretowicz A., Byks H., Sadurska K., Wysocki H. Polymorphonuclear neutrophils adherence, superoxide anion (O2-) production and HBA1 level in diabetic patients. Diabetes Res Clin Pract. 21:1993;109-114.
13. Olsen J.A., Whitelaw C.M., McHardy K.C., Pearson D.W.M., Forrester J.V. Soluble leukocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia. 40:1997;1166-1171.
14. Shah S.V., Wallin J.D., Eilen S.D. Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J Clin Endocrinol Metab. 57:1983;402-409.
15. Freedman S.F., Hatchell D.L. Enhanced superoxide radical production by stimulated polymorphonuclear leukocytes in a cat model of diabetes. Exp Eye Res. 55:1992;767-773.
16. Bullard S.R., Hatchell D.L., Cohen H.J., Rao K.M.K. Increased adhesion of neutrophils to retinal vascular endothelial cells exposed to hyperosmolarity. Exp Eye Res. 58:1994;641-647.
17. McLeod D.S., Lefer D.J., Merges C., Lutty G.A. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol. 147:1995;642-653.
18. Schroder S., Palinski W., Schmid-Schonbein G.W. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol. 139:1991;81-100.
19. Miyamoto K., Hiroshiba N., Tsujikawa A., Ogura Y. In vitro demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci. 39:1998;2190-2194.
20. Patz A., Maumenee A.E. Studies on diabetic retinopathy. I. Retinopathy in a dog with spontaneous diabetes mellitus. Am J Ophthalmol. 54:1962;532-541.
21. Hausler H.R., Sibay T.M., Campbell J. Retinopathy in a dog following diabetes induced by growth hormone. Diabetes. 13:1964;122-126.
22. Engerman R.L., Kramer J.W. Dogs with induced or spontaneous diabetes as models for the study of human diabetes mellitus. Diabetes. 31(Suppl 1 Pt 2):1982;26-29.
23. Engerman R.L., Kern T.S. Experimental galactosemia produces diabetic-like retinopathy in dogs. Diabetes. 33:1984;97-100.
24. Kador P.F., Akagi Y., Terubayashi H., Wyman M., Kinoshita J.H. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol. 106:1988;1099-1102.
25. Kador P.F., Akagi Y., Takahashi Y., Ibeke H., Wyman M., Kinoshita J.H. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol. 108:1990;1301-1309.
26. Takahashi Y., Wyman M., Frederick F. III, Kador P.F. Diabeteslike proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol. 110:1992;1295-1302.
27. Kador P.F., Takahashi Y., Myman M., Ferris F. III Diabeteslike proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol. 113:1995;352-354.
28. Fukase S., Sato S., Secchi E.F., Gery I., Kador P.F. Decreased lymphocyte blastformation in long term galactose-fed dogs. Int J Diabetes. 3:1995;91-97.
29. Fukase S., Sato S., Mori K., Secchi E.F., Kador P.F. Polyol pathway and NADPH-dependent reductases in dog leukocytes. J Diabet Complications. 10:1996;304-313.
30. Voyta J.C., Via D.P., Butterfield C.E., Zetter B.R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol. 99:1984;2034-2040.
31. Savill J., Haslett C. Granulocyte clearance by apoptosis in the resolution of inflammation. Semin Cell Biol. 6:1995;385-393.
32. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol. 61:1997;375-380.
33. Darby I.A., Bisucci T., Hewitson T.D., MacLellan D.G. Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int J Biochem Cell Biol. 29:1997;191-200.
34. Takahashi Y, Kador PF: Lymphocytic thyroiditis in galactose-fed dogs. US-Japan Aldose Reductase Workshop, Feb. 12-16 Kona, Hawaii, p. 78.
35. Schmid-Schonbein G.W. The damaging potential of leukocyte activation in the microcirculation. Angiology. 44:1993;45-46.
36. Darnay B.G., Aggarwal B.B. Early events in TNF signalling. A story of associations and dissociations J Leukoc Biol. 61:1997;559-566.
37. Xia P., Inoguchi T., Kern T., Engerman R.L., Oates P.J., King G.L. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hyperglycemia. Diabetes. 43:1994;1122-1129.
38. Keogh R.J., Dunlop M.E., Larkins R.G. Effect of inhibition of aldose reductase on glucose flux, diacylglycerol formation, protein kinase C, and phospholipase A2 activation. Metabolism. 46:1997;41-47.
39. Kador P.F., Takahashi Y., Sato S., Wyman M. Amelioration of diabetes-like retinal changes in galactose-fed dogs. Prevent Med. 23:1994;1925-1991.
40. Neuenschwander H., Takahashi Y., Kador P.F. Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175. J Ocul Pharmacol Ther. 13:1997;517-528.
41. Sato S., Takahashi Y., Wyman M., Kador P.F. Progression of sugar cataract in the dog. Invest Ophthalmol Vis Sci. 32:1991;1925-1931.
42. Sato S., Mori K., Wyman M., Kador P.F. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175. Exp Eye Res. 66:1998;217-222.